Theragesic Creme
NDC Package 71269-005-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Theragesic Creme is directions Adults and children 12 or more years of age. Marketed by Mainpointe Pharmaceuticals, Llc, this product is identified by NDC 71269-005 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
71269-005-03
Package Description
1 TUBE in 1 CARTON / 85 g in 1 TUBE
Product Code
71269-005
11-Digit Billing Format
71269000503
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
85 GM
RxNorm Crosswalk
  • RxCUI: 259203 - menthol 1 % / methyl salicylate 15 % Topical Cream
  • RxCUI: 259203 - menthol 10 MG/ML / methyl salicylate 150 MG/ML Topical Cream
  • RxCUI: 724160 - THERA-GESIC Pain Relieving Creme 1 % / 15 % Topical Cream
  • RxCUI: 724160 - menthol 10 MG/ML / methyl salicylate 150 MG/ML Topical Cream [Thera-Gesic]
  • RxCUI: 724160 - Thera-Gesic (menthol 10 MG/ML / methyl salicylate 150 MG/ML) Topical Cream

Clinical Specifications

Proprietary Name
Theragesic Creme
Dosage Form
-
Usage Information
Directions Adults and children 12 or more years of age. Apply thin layers of crème into and around the sore or painful area, not more than 3 to 4 times daily. The number of thin layers controls the intensity of the action of THERA-GESIC ®. One this layer provides a mild effect, two thin layers provide a strong effect and three thin layers provide a very strong effect. SEE WARNINGS. Wash hands thoroughly after application.

Regulatory & Marketing

Labeler Name
Mainpointe Pharmaceuticals, Llc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
01-01-1981
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71269-005-03 identifies a specific commercial package of 1 tube in 1 carton / 85 g in 1 tube of Theragesic Creme, labeled by Mainpointe Pharmaceuticals, Llc. This product is billed per "GM" gram and contains an estimated amount of 85 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mainpointe Pharmaceuticals, Llc on January 01, 1981. The current certification is valid through December 31, 2021.

How is this Mainpointe Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71269000503. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 85 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71269-005-03
11-Digit CMS (5-4-2)
71269-0005-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.